Microbion's Topical Pravibismane Phase 1b Moderate or Severe Diabetic Foot Ulcer Infection Study is Published in International Wound Journal

/PRNewswire/ - Microbion Corporation today announced that the company has published results from its topical pravibismane Phase 1b study in the peer-reviewed...

Related Keywords

Vancouver ,British Columbia ,Canada ,Benjamina Lipsky ,Brett Baker ,Davidg Armstrong ,Cystic Fibrosis Foundation ,Microbion Corporation ,International Wound Journal ,International Wound ,Adjunctive Therapy ,Severe Diabetic Foot Infections ,Medicine Emeritus ,Keck School ,Southern California ,Chief Innovation Officer ,Orphan Drug ,Fast Track ,Qualified Infectious Disease Product ,